Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Return on Equity (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Return on Equity over the past 9 years, most recently at 0.15% for Q4 2023.

  • For Q4 2023, Return on Equity rose 16.0% year-over-year to 0.15%; the TTM value through Dec 2023 reached 0.15%, up 16.0%, while the annual FY2023 figure was 0.04%, 3.0% down from the prior year.
  • Return on Equity for Q4 2023 was 0.15% at Corbus Pharmaceuticals Holdings, up from 0.1% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.15% in Q4 2023 and troughed at 0.1% in Q3 2023.
  • A 5-year average of 0.02% and a median of 0.02% in 2021 define the central range for Return on Equity.
  • On a YoY basis, Return on Equity climbed as much as 16bps in 2023 and fell as far as -9bps in 2023.
  • Year by year, Return on Equity stood at 0.04% in 2019, then increased by 22bps to 0.03% in 2020, then soared by 77bps to 0.01% in 2021, then crashed by -39bps to 0.01% in 2022, then skyrocketed by 1469bps to 0.15% in 2023.
  • Business Quant data shows Return on Equity for CRBP at 0.15% in Q4 2023, 0.1% in Q3 2023, and 0.03% in Q2 2023.